|
|
|
|
| | | |
|
|
- Developed tomotherapy – a specialized form
of radiation therapy targeting cancer cells, avoiding other cells
and organs.
- Instrumental in Wisconsin law improving patient access
to clinical trials.
- Leading developer of virtual colonoscopy.
- Two $7 million federal grants received to fund housing for interdisciplinary
prostate and breast cancer research.
- Established a palliative care unit at UW Hospital and Clinics.
- Chosen to lead a consortium of five institutions to conduct multiple
Phase I and II clinical trials of cancer chemopreventive agents.
- Developed tamoxifen, one of the best therapies for treating and
preventing breast cancer.
- Introduced 5-Fluorouracil, which is widely used to treat breast,
ovarian, stomach and colon cancers.
- Developed the conceptual basis for combination drug therapy.
- Led the first clinical trials with DFMO, a potential cancer-preventing
agent that slows an enzyme involved in tumor growth.
- Launched the world’s first test of “gene gun” technology
in cancer patients.
- One of three centers to participate in the national endostatin
Phase I clinical trial.
- Sponsored the nation’s first telephone-based cancer
helpline, which has now become the National Cancer Institute’s
Cancer Information Service.
- First radiation oncology department in country to have CT/PET scanning
for treatment planning.
- Led the development of the Wisconsin Cancer Council and Wisconsin
Cancer Pain Initiative.
View list of UWCCC 2007 Significant Published Accomplishments
View featured UWCCC Presentations/Posters at
Major Meetings
|